Epidermolysis bullosa simplex generalized severe induces a Th17 response and is improved by Apremilast treatment.

Fiche publication


Date publication

juin 2018

Journal

The British journal of dermatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VABRES Pierre


Tous les auteurs :
Castela E, Tulic MK, Rozières A, Bourrat E, Nicolas JF, Kanitakis J, Vabres P, Bessis D, Mazereeuw J, Morice-Picard F, Baty D, Berard F, Lacour JP, Passeron T, Chiaverini C

Résumé

Epidermolysis bullosa simplex generalized severe is a genetic disorder caused by mutation in KRT5 or KRT14 genes. Usually considered as a mechanical disease, recent data argue for additional inflammatory mechanisms.

Référence

Br. J. Dermatol.. 2018 Jun 22;: